Hepatic and hippocampus iron status is not altered in response to increased serum ceruloplasmin and serum "free" copper in wistar rat model for non-wilsonian brain copper toxicosis

Biological Trace Element Research

Volumn 154, Issue 3, 2013, Pages 403-411

  Pal, Amit ^a   Kumar Vasishta, Rakesh ^a   Prasad, Rajendra ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ceruloplasmin; Copper intoxication; Neurodegeneration; Serum "free" copper

Indexed keywords

CERULOPLASMIN; COPPER; COPPER CHLORIDE; FERRIC FERROCYANIDE; HEMOSIDERIN; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; HIPPOCAMPUS; HISTOPATHOLOGY; INTOXICATION; KUPFFER CELL; LIVER LEVEL; LIVER PARENCHYMA; LIVER SINUSOID; MALE; MEMORY DISORDER; NEUROTOXICITY; NONHUMAN; RAT;

RATTUS; RATTUS NORVEGICUS;

ALKALINE PHOSPHATASE; ANIMALS; CERULOPLASMIN; COPPER; DISEASE MODELS, ANIMAL; HEMOSIDERIN; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; IRON; KUPFFER CELLS; L-LACTATE DEHYDROGENASE; LIVER; MALE; MEMORY DISORDERS; NEURODEGENERATIVE DISEASES; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC;

EID: 84882664692     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9753-1     Document Type: Article

References (54)

1. Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases. Pharmacol Ther 133(2):177-188. doi: 10.1016/j.pharmthera.2011.10.006
2. Georgopoulos PG, Roy A, Yonone-Lioy MJ, Opiekun RE, Lioy PJ (2001) Environmental copper: its dynamics and human exposure issues. J Toxicol Environ Health B Crit Rev 4(4):341-394. doi: 10.1080/109374001753146207
3. Rivera-Mancia S, Perez-Neri I, Rios C, Tristan-Lopez L, Rivera-Espinosa L, Montes S (2010) The transition metals, copper, and iron in neurodegenerative diseases. Chem Biol Interact 186(2):184-199. doi: 10.1016/j.cbi.2010.04.010
4. Gambling L, McArdle HJ (2004) Iron, copper, and fetal development. Proc Nutr Soc 63(4):553-562
5. Sharp P (2004) The molecular basis of copper and iron interactions. Proc Nutr Soc 63(4):563-569
6. Ranganathan PN, Lu Y, Jiang L, Kim C, Collins JF Serum ceruloplasmin protein expression and activity increases in iron-deficient rats and is further enhanced by higher dietary copper intake. Blood 118(11):3146-3153. doi: 10.1182/blood-2011-05-352112
7. Squitti R, Ventriglia M, Barbati G, Cassetta E, Ferreri F, Dal Forno G, Ramires S, Zappasodi F, Rossini PM (2007) 'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm 114(12):1589-1594. doi: 10.1007/s00702-007-0777-6
8. Kristinsson J, Snaedal J, Torsdottir G, Johannesson T Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies. Neuropsychiatr Dis Treat 8:515-521. doi: 10.2147/NDT.S34729
9. Brewer GJ, Kanzer SH, Zimmerman EA, Celmins DF, Heckman SM, Dick R Copper and ceruloplasmin abnormalities in Alzheimer's disease. Am J Alzheimers Dis Other Demen 25(6):490-497. doi: 10.1177/1533317510375083
10. Brewer GJ (2010) Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 23(2):319-326. doi: 10.1021/tx900338d
11. Desai V, Kaler SG (2008) Role of copper in human neurological disorders. Am J Clin Nutr 88(3):855S-858S
12. Salustri C, Barbati G, Ghidoni R, Quintiliani L, Ciappina S, Binetti G, Squitti R (2010) Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clin Neurophysiol 121(4):502-507. doi: 10.1016/j.clinph.2009.11.090
13. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water-induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 100(19):11065-11069. doi: 10.1073/pnas. 1832769100
14. Lu J, Zheng YL, Wu DM, Sun DX, Shan Q, Fan SH (2006) Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis. FEBS Lett 580(28-29):6730-6740. doi: 10.1016/j.febslet.2006.10.072
15. Mao X, Ye J, Zhou S, Pi R, Dou J, Zang L, Chen X, Chao X, Li W, Liu M, Liu P (2012) The effects of chronic copper exposure on the amyloid protein metabolism associated genes' expression in chronic cerebral hypoperfused rats. Neurosci Lett. doi: 10.1016/j.neulet.2012.04.030
16. An L, Liu S, Yang Z, Zhang T Cognitive impairment in rats induced by nano-CuO and its possible mechanisms. Toxicol Lett 213(2):220-227. doi: 10.1016/j.toxlet.2012.07.007
17. Pal A, Badyal RK, Vasishta RK, Attri SV, Thapa BR, Prasad R Biochemical, Histological, and Memory Impairment Effects of Chronic Copper Toxicity: A Model for Non-Wilsonian Brain Copper Toxicosis in Wistar Rat. Biol Trace Elem Res. doi: 10.1007/s12011-013-9665-0
18. Narasaki M (1980) Laboratory and histological similarities between Wilson's disease and rats with copper toxicity. Acta Med Okayama 34(2):81-90
19. Scriver CR (1995) The Metabolic Basis of Inherited Disease. McGraw-Hill Information Services Company
20. European Association for Study of L EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 56 (3):671-685. doi: 10.1016/j.jhep.2011.11.007
21. Prasad R, Kaur G, Walia BN (1998) A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives. Biol Trace Elem Res 65(2):153-165. doi: 10.1007/bf02784267
22. Bancroft JD, Gamble M (2008) Theory and Practice of Histological Techniques. Elsevier Science Health Science Division
23. Hall AP, Davies W, Stamp K, Clamp I, Bigley A Comparison of Computerized Image Analysis with Traditional Semiquantitative Scoring of Perls' Prussian Blue Stained Hepatic Iron Deposition. Toxicol Pathol. doi: 10.1177/0192623313476576
24. Scheuer PJ, Williams R, Muir AR (1962) Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 84:53-64
25. Barry M (1974) Liver iron concentration, stainable iron, and total body storage iron. Gut 15(5):411-415
26. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini PM (2006) Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 67(1):76-82. doi: 10.1212/01.wnl. 0000223343.82809.cf
27. Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, Vernieri F, Rossi L, Baldassini M, Rossini PM (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer's disease. Neurology 64(6):1040-1046. doi: 10.1212/01.wnl.0000154531.79362.23
28. Arnal N, Cristalli DO, de Alaniz MJ, Marra CA Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res 1319:118-130. doi: 10.1016/j.brainres.2009.11.085
29. Brewer GJ Metals in the causation and treatment of Wilson†™s disease and Alzheimer’s disease, and copper lowering therapy in medicine. Inorg Chim Acta 393(0):135-141. doi: 10.1016/j.ica.2012. 06.014
30. Texel SJ, Xu X, Harris ZL (2008) Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans 36(6):1277-1281. doi: 10.1042/BST0361277
31. Sternlieb I, Morell AG, Tucker WD, Greene MW, Scheinberg IH (1961) The incorporation of copper into ceruloplasmin in vivo: studies with copper and copper. J Clin Invest 40(10):1834-1840. doi: 10.1172/JCI104407
32. Matsuda I, Pearson T, Holtzman NA (1974) Determination of apoceruloplasmin by radioimmunoassay in nutritional copper deficiency, Menkes' kinky hair syndrome, Wilson's disease, and umbilical cord blood. Pediatr Res 8(10):821-824. doi: 10.1203/00006450-197410000-00001
33. Multi-copper oxidases (1997). World Scientific, Singapore
34. Holtzman NA, Elliott DA, Heller RH (1966) Copper intoxication. Report of a case with observations on ceruloplasmin. N Engl J Med 275(7):347-352
35. Monnot AD, Behl M, Ho S, Zheng W (2011) Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency. Toxicol Appl Pharmacol 256(3):249-257. doi: 10.1016/j.taap.2011. 02.003
36. Choi BS, Zheng W (2009) Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res 1248:14-21. doi: 10.1016/j.brainres. 2008.10.056
37. Roberts EA, Cox DW (1998) Wilson disease. Baillieres Clin Gastroenterol 12(2):237-256
38. MacDonald RA (1967) Tissue iron and hemochromatosis. Comparative studies in Denver and Boston. Arch Pathol 84(5):543-551
39. Macdonald RA, Pechet GS (1964) Liver and tissue iron: comparative studies and significance for hemochromatosis. Arch Pathol 77:348-353
40. Weinfeld A, Lundin P, Lundvall O (1968) Significance for the diagnosis of iron overload of histochemical and chemical iron in the liver of control subjects. J Clin Pathol 21(1):35-40
41. Ding B, Chen KM, Ling HW, Sun F, Li X, Wan T, Chai WM, Zhang H, Zhan Y, Guan YJ (2009) Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J Magn Reson Imaging 29(4):793-798. doi: 10.1002/jmri.21730
42. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron, and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158(1):47-52
43. Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, Beyreuther K, Carrington D, Masters CL, Cherny RA, Cappai R, Bush AI (2004) Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. FASEB J 18(12):1427-1429. doi: 10.1096/fj.04-1890fje
44. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38(24):7609-7616. doi: 10.1021/bi990438f
45. Schubert D, Chevion M (1995) The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun 216(2):702-707
46. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52(2):515-520
47. Tiffany-Castiglioni E, Hong S, Qian Y (2011) Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci 29(8):811-818. doi: 10.1016/j.ijdevneu.2011.09.004
48. Allaman I, Belanger M, Magistretti PJ Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci 34(2):76-87. doi: 10.1016/j.tins.2010.12.001
49. Gibbs ME, Hutchinson D, Hertz L (2008) Astrocytic involvement in learning and memory consolidation. Neurosci Biobehav Rev 32(5):927-944. doi: 10.1016/j.neubiorev.2008.02.001
50. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF, Masters CL, Fairlie DP, Tanzi RE, Bush AI (1999) Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274(52):37111-37116
51. White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, Multhaup G, Beyreuther K, Masters CL, Cappai R (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842(2):439-444
52. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, Ciccotosto GD, Rogers JT, Bush AI Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142(6):857-867. doi: 10.1016/j.cell.2010. 08.014
53. Behnke S, Berg D, Becker G (2003) Does ultrasound disclose a vulnerability factor for Parkinson's disease? J Neurol 250 Suppl 1:I24-27. doi: 10.1007/s00415-003-1104-0 [doi]
54. Matyash V, Kettenmann H Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 63(1-2):2-10. doi: 10.1016/j.brainresrev.2009.12.001